<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0385">
 <label>77</label>
 <element-citation publication-type="journal" id="rf0385">
  <person-group person-group-type="author">
   <name>
    <surname>Sehailia</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Chemat</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>In-silico studies of antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19</article-title>
  <source>ChemRxiv</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.26434/chemrxiv.12098652.v1</pub-id>
 </element-citation>
</ref>
